Your session is about to expire
← Back to Search
Device
Microtech System for Heart Failure (Microtech-LVAD Trial)
N/A
Waitlist Available
Research Sponsored by Microtech Medical Technologies, Ltd
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patient is scheduled to undergo an elective LVAD implantation via midline sternotomy based on routine practice at the participating center
Must not have
For an intended LA implant, patient has a device implanted in the left atrial appendage (e.g., WATCHMAN or similar device) or a mechanical mitral valve
Patient has severe mitral regurgitation (for an LA implant) or severe tricuspid regurgitation (for an RA implant) that is not intended to be corrected during the LVAD implantation
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month, 3-6 months , 9months and 12 month
Awards & highlights
No Placebo-Only Group
Summary
This trial will involve 15 patients who will receive a heart pump device called LVAD via surgery. The first few patients will have the device placed in the right side of the heart, and then in
Who is the study for?
This trial is for patients who are scheduled to receive a Left Ventricular Assist Device (LVAD) through midline sternotomy, based on routine clinical decisions. It's not clear what specific conditions exclude someone from participating.
What is being tested?
The study tests the safety and accuracy of the Microtech sensor pressure system in patients getting an LVAD implant. Initially, 5 patients will have it placed in the right atrium (RA), with subsequent placements in the left atrium (LA) unless there's a high risk of right heart failure post-LVAD.
What are the potential side effects?
Since this trial focuses on device implementation rather than medication, side effects may include typical surgical risks such as infection or complications related to device placement like bleeding or improper sensor readings.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am scheduled for a heart pump implant surgery through the chest.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have a device like WATCHMAN implanted in my heart's left atrial appendage or a mechanical mitral valve.
Select...
I have severe heart valve issues not being fixed during my heart pump implant.
Select...
I have been diagnosed with a heart tumor known as atrial myxoma.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 month, 3-6 months , 9months and 12 month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month, 3-6 months , 9months and 12 month
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Co-Primary Efficacy Endpoint
Co-Primary Safety Endpoint
Secondary study objectives
Accuracy of Microtech pressure measurements in comparison to those obtained simultaneously by pulmonary artery catheter
Anatomic stability of the implant over the observation period
Correlation of changes of sensor-measured atrial pressure
+3 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Microtech SystemExperimental Treatment1 Intervention
Microtech System
Find a Location
Who is running the clinical trial?
Microtech Medical Technologies, LtdLead Sponsor